Amylyx Pharmaceuticals Inc (AMLX): Narxning sotuvga nisbati
Amylyx Pharmaceuticals (AMLX) kompaniyasining sotuvlarga nisbatan narx koeffitsiyenti o'zgarishi AQShdagi neyrodegeneratsiya dori vositalari ishlab chiqarilishi bilan bog'liq bo'lib, bunda -2318.10 ushbu metrika uchun yangi qiymatga aylanadi. Tartibga soluvchi o'zgarishlar xavfini kamaytirish uchun ALS va Altsgeymer kasalliklarini davolash vositalarining ishlab chiqilishi biznes barqarorligini mustahkamlaydi. Bundan tashqari, molekulalarni robotlashtirilgan skriningi joriy etilishi yangi birikmalarni qidirishni tezlashtirib, laboratoriya jarayonlarini optimallashtiradi.
%20P%2FS%20multiplikatori&width=1200&height=400&colorIndex=0&v=mwejrfjc.e5f-7d7lczk&start=20220704&end=20261113&filename=GURU_Markets_-_AMLX_-_Amylyx-Pharmaceuticals_-_PS-Multiple "AMLX - Amylyx Corp Bozor kapitallashuvining daromadga nisbati 04.07.2022 - 04.03.2026 oraligʻida | 👁️GURU.Markets👁️")
Amylyx (AMLX) kompaniyasi koʻrsatkichlari kesimi va tahlili
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- birja kapitallashuvi ma'lumotlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Amylyx Pharmaceuticals|AMLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati Amylyx Corp|AMLX - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Amylyx|AMLX - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Amylyx Pharmaceuticals|Shoshilinch likvidlik amylyx.com
- foyda va qiymat multiplikatorlari haqida ma'lumot:
AMLX - Sof daromad|Prognoz qilingan kelajakdagi foyda Amylyx Pharmaceuticals|AMLX - Narx-foyda koeffitsiyenti|Kapitalizatsiyaning kelajakdagi foydaga nisbati Amylyx Pharmaceuticals Inc|AMLX - PEG multiplikatori|Kompaniyaning to‘liq qiymatining amortizatsiyadan oldingi operatsion foydaga nisbati Amylyx|AMLX - EBITDA operatsion foydasi|So'nggi 12 oy davomida bir aksiya uchun sof foyda Amylyx Pharmaceuticals|AMLX - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi amylyx.com|AMLX - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Amylyx Pharmaceuticals
- emitentning tushumi va sotuvlari tafsilotlari:
Kompaniyaning umumiy tahlili:AMLX amylyx.com
P/S koeffitsiyenti biznesning bozor qiymatini uning daromadlariga nisbatan belgilaydi, bu esa sotilgan mahsulotning har bir birligi uchun to'langan premiumni baholash imkonini beradi. P/S tebranishlarini tahlil qilish orqali investorlar, sikllikka bog'liq bo'lmagan nevrologiya sektorida talab barqaror qolgan holda, tartibga soluvchi tasdiqlarning Amylyx Pharmaceuticals (AMLX) kapitalizatsiyasiga ta'sirini aniqlashlari mumkin, chunki ushbu koeffitsiyentdagi keskin o'zgarishlar odatda muvaffaqiyatli klinik sinovlardan dalolat beradi.
Raqobatdosh kompaniyalar
BIIB (biogen.com) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Neurocrine Biosciences, Inc. NBIX|RGC (Regencell Bioscience Ltd) - Narxning sotuvga nisbati|Axsome Therapeutics Inc - P/S multiplikatori|Bozor kapitallashuvining daromadga nisbati ACAD (ACADIA Corp)|XENE: P/S multiplikatori|vikingtherapeutics.com (VKTX) - P/S multiplikatori|Narxning daromadga nisbati Supernus|CPRX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Denali Therapeutics Inc (DNLI)|Kapitalizatsiyaning daromadga nisbati Harmony Corp HRMY|P/S multiplikatori BHVN (Biohaven Ltd.)|P/S multiplikatori trevitherapeutics.com TRVI|Praxis Precision Medicines, Inc. - P/S multiplikatori|Anavex (AVXL) - Kapitalizatsiyaning daromadga nisbati|CBLL: P/S multiplikatori|Sotuvga nisbatan narx Prothena Corp (PRTA)|Kapitalizatsiyaning daromadga nisbati ALEC|P/S multiplikatori annexonbio.com|Kapitalizatsiyaning daromadga nisbati OMER (Omeros Corporation)|Kapitalizatsiyaning sotish hajmiga nisbati NGNE|P/S multiplikatori ACIU (AC Immune Corp)|Narx/daromad koeffitsiyenti Voyager Corp (VYGR)|Neumora Therapeutics - P/S multiplikatori|scilexholding.com (SCLX) - Kapitalizatsiyaning daromadga nisbati|TVGN: P/S multiplikatori|Alpha Cognition Inc. (ACOG) - P/S multiplikatori|Narxning daromadga nisbati Cognition Therapeutics, Inc.|Narxning daromadga nisbati IKT|Narxning daromadga nisbati Cassava Sciences, Inc. (SAVA)|Narx/daromad koeffitsiyenti assertiotx.com|P/S multiplikatori COYA (Coya Therapeutics)|P/S multiplikatori VistaGen Therapeutics, Inc. VTGN|OVID - Narxning daromadga nisbati|Acumen Pharmaceuticals, Inc (ABOS) - Kapitalizatsiyaning daromadga nisbati|CervoMed Inc. (CRVO) - Narxning daromadga nisbati|ATHE (Alterity Therapeutics Limited) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati CLNN|Kapitalizatsiya va daromad nisbati PEPG (PepGen Corp)|Narxning daromadga nisbati Jupiter Neurosciences (JUNS)|Relmada Corp - Kapitalizatsiya va daromad nisbati|P/S multiplikatori ANVS (Annovis Bio, Inc.)|Grace Therapeutics Inc (GRCE) - Sotuvga nisbatan narx|AIFF: Kapitalizatsiyaning daromadga nisbati|KLTO - P/S multiplikatori|neurosense-tx.com (NRSN) - Narxning daromadga nisbati|Reviva Pharmaceuticals, Inc. - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati MetaVia Inc.|Sotuvga nisbatan narx neuraxis.com NRXS|P/S multiplikatori HSDT|P/S multiplikatori passagebio.com (PASG)|Narxning daromadga nisbati Neuphoria Therapeutics NEUP|NERV - Kapitalizatsiyaning daromadga nisbati|ATHA: Kapitalizatsiyaning daromadga nisbati|Sotuvga nisbatan narx addextherapeutics.com|alzamend.com (ALZN) - Narxning daromadga nisbati|CYCN (Cyclerion Therapeutics, Inc.) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PTIX|Sotuvga nisbatan narx Pasithea KTTA|Kapitalizatsiyaning daromadga nisbati CRGT (Cortigent, Inc.)|avenuetx.com - Kapitalizatsiya va daromad nisbati|BrainStorm Cell Therapeutics - Kapitalizatsiyaning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati CARA|CHRO - Narxning daromadga nisbati|Narxning sotuvga nisbati ELYM|ITCI: P/S multiplikatori|longboardpharma.com - Bozor kapitallashuvining daromadga nisbati|MRNS (Marinus Pharmaceuticals, Inc.) - P/S multiplikatori|P/S multiplikatori NKGen Biotech Inc|Narxning daromadga nisbati NeuroBo (NRBO)|SAGE (Sage Therapeutics Inc) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Synaptogenix, Inc. SNPX|TRVN - Kapitalizatsiyaning daromadga nisbati|Vigil Neuro - P/S multiplikatori|WENA - P/S multiplikatori|CERE: P/S multiplikatori
